Aquestive Therapeutics AQST
NASDAQ AQST
$4.66 +0.16 (+3.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Net Equity Issued and Repurchased (2020 - 2021)

Aquestive Therapeutics (AQST) posted quarterly Net Equity Issued and Repurchased of $9.9 million for Q1 2021, up 63.35% quarter-over-quarter from $6.1 million in Q4 2020.

Aquestive Therapeutics (AQST) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

Aquestive Therapeutics' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $9.9 million for Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Aquestive Therapeutics 583.72 Mn 583.72 Mn 9.80 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 9.89 Mn
Mar 31, 2021 9.89 Mn
Dec 31, 2020 6.06 Mn
Dec 31, 2020 6.06 Mn